Dr. Sabeen T. Lulu, MD

Dr. Lulu practices at Mercy Medical Group, A Service Of Dignity Health Medical Foundation in Carmichael, California.

Dr. Lulu's NPI, 1104081298, was assigned on July 28, 2008. Dr. Lulu graduated from Other in 2005. Dr. Lulu holds California license A120357.

Dr. Lulu's primary practice is Mercy Medical Group, A Service of Dignity Health Medical Foundation, at 6555 Coyle Ave Suite 280 Suite 280, Carmichael, CA 95608-0302. The practice phone is (916) 536-3540.

Dr. Lulu's primary practice is Mercy Medical Group, A Service Of Dignity Health Medical Foundation in Carmichael, California. Dr. Lulu is also affiliated with Dignity Health - Mercy San Juan Medical Center. The medical group on file is Mercy Medical Group. Dmand AI also links Dr. Lulu to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lulu practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Lulu's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Lulu is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Lulu's licenses on file in 2 states: California and Michigan.

Dmand AI lists cerebrovascular disease, epilepsy, fibromyalgia and chronic pain, head injury, hereditary polyneuropathy, migraine and chronic headache, mobility impairment and multiple sclerosis among the conditions Dr. Lulu treats.

CMS data shows 6,739 Medicare services from Dr. Lulu across 10 procedure codes in 2024, for 304 Medicare patients. Medicare paid $93,580 for them.

CMS counts 304 Medicare patients who saw Dr. Lulu in 2024. The largest group is 65 to 74, with 135 patients. 73% of them have high cholesterol, and 63% have high blood pressure. 32% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lulu's median patient age at 56, with 76% women.

In 2024, Dr. Lulu wrote 2,447 Medicare Part D claims for 308 patients. 85% of them were for generic drugs. CMS names the drug for 2,146 of them, across 53 drugs with 11 or more claims each, at $2,333,955 in total drug cost. In 2023, CMS named 2,494 claims across 59 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Lulu for performance year 2024, reported through an alternative payment model (APM). Dr. Lulu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lulu as offering telehealth.

Dmand AI links 9 papers to Dr. Lulu, published from 2012 to 2018. 2016 was the busiest year, with 3. The most frequent topics are Multiple Sclerosis, Relapsing-Remitting, Age of Onset and Disease Progression. Dr. Lulu has published most often in Mult Scler Relat Disord. Dr. Lulu's most frequent co-authors are Jennifer S. Graves, MD, Emmanuelle L. Waubant, MD and Gregory Scott Aaen, MD.

Dmand AI links Dr. Lulu to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Multiple Sclerosis, Relapsing-Remitting and Multiple Sclerosis.

CMS Open Payments shows 249 general payments to Dr. Lulu from 14 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 76% of the total. Biogen, Inc. paid the most, $142,252.

Dmand AI lists 1 award for Dr. Lulu, most recently CMS Stage 1 EHR in 2013.

Dr. Lulu graduated from Other in 2005.

Dr. Lulu is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.